GRB10 and neoplasm: Together, these data indicate that Grb10 modulates Ras signaling in untransformed cells as well as tumor cells, and that loss of Grb10 in untransformed cells increases the magnitude and duration of Ras effector activation despite reduced insulin receptor levels.